1. Interstitial lung disease: a commentary

   • Esam H. Alhamad

   Invited Commentary 19 February 2013 Pages: 69 - 71

2. Targeting angiogenesis in advanced non-small-cell lung cancer: are biomarkers needed?

   • G. Metro
   • M. Cenci
   • L. Crinò

   Hot Topic 13 April 2013 Pages: 72 - 78

3. EGFR mutations in malignant pleural effusions from lung cancer

   • Clayton J. Shamblin
   • Nichole T. Tanner
   • Gerard A. Silvestri

   Pleural Diseases and Mesothelioma (YCG Lee, Section Editor) 14 March 2013 Pages: 79 - 87

   

4. New agents for pleurodesis

   • Richard W. Light

   Pleural Diseases and Mesothelioma (YCG Lee, Section Editor) 02 April 2013 Pages: 88 - 92

5. Advantages of indwelling pleural catheters for management of malignant pleural effusions

   • Rogier C. Boshuizen
   • Rajesh Thomas
   • Y. C. Gary Lee

   Pleural Diseases and Mesothelioma (YCG Lee, Section Editor) 08 March 2013 Pages: 93 - 99

   

6. Prognostic factors for malignant pleural mesothelioma

   • Fraser J. H. Brims
   • Nick A. Maskell

   Pleural Diseases and Mesothelioma (YCG Lee, Section Editor) 26 February 2013 Pages: 100 - 108

7. Management options for the complicated pleural space

   • David Hsia
   • Ali I. Musani

   Pleural Diseases and Mesothelioma (YCG Lee, Section Editor) 28 February 2013 Pages: 109 - 117

8. Sleep-disordered breathing in pregnancy

   • Rosalia Silvestri
   • Irene Aricò

   Sleep Medicine (V Castronovo, Section Editor) 02 April 2013 Pages: 118 - 122

9. Chronic obstructive pulmonary disease and sleep

   • Teofilo Lee-Chiong

   Sleep Medicine (V Castronovo, Section Editor) 05 April 2013 Pages: 123 - 129